Stopping blood thinners after drug-coated balloon treatment
Part of Heart & circulation clinical trials.
This study looks at whether it is safe to stop taking antiplatelet blood thinners in patients who had a drug-coated balloon procedure at least a year ago and have had no heart problems or major bleeding since then.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 19 years or older.
- You had a drug-coated balloon procedure at least 12 months ago.
- You have not had a heart attack, stroke, or needed another procedure on the same blood vessel since that treatment.
- You have not had any major bleeding since that treatment.
- You are currently taking antiplatelet medication (like aspirin or clopidogrel).
- You do not have other blood vessel disease that requires long-term blood thinners.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests how the way a drug-coated balloon is used during a heart procedure affects outcomes for people with stable heart disease or unstable angina. It may help doctors find the best technique to keep arteries open.
This study tracks patients who receive a special balloon coated with medicine (paclitaxel) to open blocked heart arteries. It aims to understand how well this treatment works for various types of blockages.
This study tests whether taking a single blood-thinning medication (instead of two) after heart stent placement is safe and effective over the long term. If you've recovered well from a stent procedure, this trial may help determine the safest way to prevent future heart problems.
This trial compares a drug-coated balloon (medicated balloon) to a drug-eluting stent (medicated mesh tube) for treating new blockages in heart arteries. It is designed for patients with a high risk of bleeding who have completed a short course of anti-clotting medication and have been event-free for at least one year.
This study records outcomes for people who get a drug-coated balloon used to treat a narrowed blood vessel after a first balloon treatment. It may help doctors understand how well this approach works in everyday care and for different patient needs.
This study compares whether patients who receive a special drug-coated balloon to open a blocked heart artery (without a stent) need to take one or two blood-thinning medications afterward. The goal is to find the safest and most effective approach for preventing future blockages.
Hear when a new Percutaneous Coronary Intervention trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.